MedTrace Logo

Sentinel Node Detection in Cervical Cancer

NCT03680833 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 226

Last updated 2018-09-26

No results posted yet for this study

Summary

Evaluation of sensitivity of Sentinel lymph nodes for detecting nodal metastases in cervical cancer

Conditions

  • Sentinel Lymph Node Biopsy

Interventions

PROCEDURE

Sentinel node detection in cervical cancer

The study intervention is the injection of tracer followed by detection and removal of sentinel lymph nodes

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Jan Persson, ass professor · Region Skane

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-15
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03680833 on ClinicalTrials.gov